ADHD, Autism and Perimenopause: Why Midlife Can Be a Turning Point for Neurodivergent Women

The Royal College of Psychiatrists has recently published a position statement on menopause and mental health, highlighting something many clinicians have long observed in practice: the menopause transition can have a significant impact on psychological wellbeing.

For many women, perimenopause is associated with changes in mood, sleep, cognition and emotional regulation. Anxiety and depressive symptoms may emerge for the first time, or previously stable mental health conditions may worsen.

One recommendation in the position statement is particularly striking from a psychiatric perspective:

In women aged 35–55, consider perimenopause or menopause in all new presentations of psychiatric disorder, cognitive change or behavioural concern

This represents an important shift in emphasis. Menopause is not solely a gynaecological issue; it is a period of life with clear psychiatric relevance.

But there is another layer to consider: what does this mean for neurodivergent women?

A perfect storm of barriers

Many neurodivergent women already face barriers in accessing healthcare. These may include difficulties navigating complex health systems, sensory or communication challenges within clinical environments, and a long history of being misunderstood or dismissed.

Clinicians may also be less familiar with how ADHD and autism present in adult women, particularly when traits have been masked or compensated for over many years.

When menopause enters the picture, these challenges can compound.

Hormonal changes during the menopause transition affect neurotransmitter systems involved in attention, mood regulation and executive functioning. For women with ADHD or autism, these changes may interact with existing neurodevelopmental differences.

The result can be a marked worsening of symptoms that were previously manageable.

Many women describe this period as a sudden loss of coping strategies that had been built over decades.

When masking stops working

A common theme reported by women presenting in midlife is that the menopause transition coincides with a reduced ability to mask or compensate for longstanding neurodevelopmental traits.

Over many years, women with ADHD or autism may develop highly sophisticated strategies to manage social expectations, organisational demands and emotional regulation. These strategies can require considerable cognitive effort and are often described as exhausting.

During perimenopause, when sleep disturbance, cognitive changes and mood instability are common, these strategies may become much harder to sustain.

As a result, some women present for the first time for assessment of ADHD or autism in their 40s or 50s.

Importantly, these are not “new” conditions. Rather, the hormonal transition may reveal patterns that have been present across the lifespan but previously remained hidden.

The risk of diagnostic overshadowing

There is also a risk that neurodevelopmental differences are overlooked entirely during this period.

Women presenting in midlife with symptoms such as:

• cognitive fog

• emotional dysregulation

• overwhelm

• executive dysfunction

• burnout

may receive diagnoses such as depression, anxiety or adjustment disorder.

These may indeed be present. However, if clinicians do not also consider the possibility of underlying ADHD or autism, important aspects of the clinical picture may be missed.

The reverse can also occur. Difficulties attributed solely to ADHD or autism may be significantly exacerbated by hormonal change.

Good assessment requires holding both possibilities in mind.

Implications for clinicians assessing ADHD and autism

For specialists assessing adult women, the RCPsych position statement reinforces several practical points.

1. Ask about menstrual and menopausal history Reproductive stage is a clinically relevant part of psychiatric assessment and should be routinely explored.

2. Consider hormonal transitions when symptoms worsen Changes in attention, emotional regulation or cognitive functioning may reflect both neurodevelopmental differences and hormonal change.

3. Be alert to late presentations of neurodivergence Midlife referrals for ADHD or autism may represent longstanding traits that have become more visible as compensatory strategies become harder to sustain.

4. Avoid diagnostic overshadowing in either direction Menopause-related changes and neurodevelopmental differences may both contribute to the clinical picture.

5. Work collaboratively across specialties Optimal care may involve psychiatry, primary care and specialist menopause services.

A moment of opportunity

Although the menopause transition is often framed in terms of difficulty, it can also be a moment of clarity.

For some women, understanding the interaction between hormonal change and neurodivergence can be profoundly validating. Experiences that previously felt confusing or self-critical can suddenly make sense within a broader framework.

The Royal College of Psychiatrists’ position statement is therefore a welcome development. It recognises menopause as an important part of psychiatric assessment and encourages clinicians to consider reproductive life stage when evaluating mental health symptoms.

For neurodivergent women in particular, this awareness may reduce the risk of missed diagnoses, improve access to appropriate care, and ultimately lead to better mental health outcomes.

Menopause should not be a blind spot in psychiatric practice, especially when assessing women for ADHD or autism in midlife.

If you are considering pursuing an assessment, you can read more about what an adult diagnostic assessment involves here.